Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · IEX Real-Time Price · USD
0.480
-0.005 (-1.09%)
Jul 26, 2024, 4:30 PM EDT - Market closed

Viracta Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
40
Market Cap
18.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TRxADE HEALTH 6.66M
Synlogic 3.21M
Singular Genomics Systems 2.49M
Lyra Therapeutics 1.68M
Aptorum Group 431.38K
iBio, Inc. 50.00K
Revenue Rankings